State Street SPDR S&P Pha... (XPH)
NYSEArca: XPH
· Echtzeitkurs · USD
72.45
+2.03 (2.88%)
Zum Schluss: Aug 18, 2026, 3:59 PM
73.09
+0.89%
Vorbörslich: 8:16 AM
State Street SPDR S&P Pharmaceuticals ETF (XPH) ETF Price, Holdings & Analysis
2.88% (1D)
| Geld | 0 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 489.39 Mio |
| NAV | 70.50 |
| Beta | 0.7 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 19.15 |
| Ausstehende Anteile | 5.5 Mio |
| Auflagedatum | Jun 19, 2006 |
| Brief | 0 |
| Volumen | 121,770 |
| Ø Vol. (20D) | 95,196 |
| Eröffnung | 71.10 |
| Vortagesschluss | 70.42 |
| Tagesspanne | 71.06 - 72.48 |
| 52-Wk Range | 45.80 - 72.49 |
| Positionen | k.A. |
| Kostenquote | 0.35% |
Über XPH
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Anlageklasse Equity
Tickersymbol XPH
Auflagedatum Jun 19, 2006
Anbieter State Street Investment Management
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 25.66% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.69% |
| Mbx Biosciences Inc | MBX | 3.22% |
| Ataibeckley Inc | ATAI | 2.88% |
| Definium Therapeutic... | DFTX | 2.84% |
| Amylyx Pharmaceutica... | AMLX | 2.29% |
| Enliven Therapeutics... | ELVN | 2.24% |
| Corcept Therapeutics... | CORT | 2.22% |
| Alumis Inc | ALMS | 2.13% |
| Nuvation Bio Inc Ord... | NUVB | 2.09% |
| Trevi Therapeutics I... | TRVI | 2.06% |
Dividenden Dividendenrendite 0.46%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 22, 2026 | $0.0590 | k.A. |
| Mar 23, 2026 | $0.0610 | k.A. |
| Dec 22, 2025 | $0.1130 | k.A. |
| Sep 22, 2025 | $0.1030 | k.A. |
| Jun 23, 2025 | $0.0960 | k.A. |
Seite 1 von 2